Black Diamond Therapeutics (BDTX) EV/EBITDA US GAAP (year values)

2021 2022 2023 2024 2025   LTM ?
EV/EBITDA ? -0.09 0.32 -0.20 -0.53 1.22   -0.42
Changes by years, y/y, % -99% -450% -163% +161% -331%    

Black Diamond Therapeutics. EV/EBITDA

Black Diamond Therapeutics. EV/EBITDA, changes, %

Black Diamond Therapeutics (BDTX) EV/EBITDA US GAAP (quarter values)

2024Q4 2025Q1 2025Q2 2025Q3 2025Q4   LTM ?
EV/EBITDA ? -0.57 11.7 2.38 5.43 0.98   -0.42
Changes by years, y/y, % +80% -678% -231% -382% -273%    
Changes by quarters, q/q, % -70% -2 158% -80% +128% -82%    

Black Diamond Therapeutics. EV/EBITDA

Black Diamond Therapeutics. EV/EBITDA, changes, y/y, %

Black Diamond Therapeutics. EV/EBITDA, changes, q/q, %